• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Vitamin and supplement data remains limited, may provide no benefit

bys25qthea
November 12, 2013
in Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Supplemental vitamins and minerals are not associated with clear benefit in preventing cardiovascular disease (CVD) or cancer, but they do not have appreciable adverse effects.

2. Pooled results from two large trials reported lower cancer incidence in men taking a multivitamin for more than 10 years, however the effect was small and not significant in women. 

Evidence Rating Level: 1 (Excellent)

Study Rundown: Nearly half of the U.S. population report use of vitamin and mineral supplements. In vitro and animal studies have shown that supplements may protect against CVD and cancer by reducing cellular damage. However, studies in humans have been equivocal at best. In 2003, the U.S. Preventive Services Task Force (USPSTF) concluded that there was insufficient evidence to recommend for or against the use of vitamins A, C, and E, multivitamins with folic acid, or antioxidant combinations for the prevention of CVD or cancer. Further, they recommended against the use of B-carotene supplements given evidence that these products may actually increase risk for developing lung cancer in vulnerable individuals. The current study reviewed additional evidence on the use of vitamin and mineral supplements among the general adult population in order to help the USPSTF update their recommendation statement. The authors concluded that there is still limited evidence to support any benefit from the use of vitamin and mineral supplementation for the prevention of cancer or CVD. Additionally, findings continue to show that B-carotene increases lung cancer risk in susceptible adults. The conclusions are limited by the fact that only primary prevention studies in adults without known nutritional deficiencies were used in the analyses. Additionally, the duration of most studies was less than 10 years. Nonetheless, the study conclusions are in line with the previous USPSTF recommendations on the use of vitamin and mineral supplements in non-deficient adults.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 45

Multivitamin use not found to be associated with mortality benefit at 20 years follow-up

The 2 Minute Medicine Podcast Episode 39

Relevant Reading: Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale

In-Depth [meta-analysis]:  Randomized, controlled trials and cohort studies that assessed the effectiveness or safety of supplements in the primary prevention of CVD, cancer, or all-cause mortality in the general adult population were included in the analysis. Studies were included if participants were community-dwelling, nutrient-sufficient adults without chronic disease or history of CVD or cancer who lived in developed countries.  The studies selected investigated the benefits and harms of multivitamin supplementation, individual or paired supplements, B-carotene, vitamin E, selenium, vitamin A, vitamin C, folic acid, vitamin D, calcium, or vitamin D and calcium in combination. Study results were stratified by supplement, and meta-analyses were conducted to estimate the effect size of supplementation on CVD incidence, cancer incidence, and all-cause mortality at the longest follow-up time point of each study. Unadjusted relative risks were calculated based on the number of events and nonevents.

26 studies (24 randomized, controlled trials and 2 cohort studies) were included in the analysis. In the studies of single and paired nutrients (including vitamins A, C, or D, folic acid, selenium, or calcium), there was little evidence to support or refute an effect on all-cause mortality, incidence of CVD, or cancer among patients. B-carotene also had no effect on these variables, however there was a probable increase in lung cancer incidence in high-risk subgroups, such as smokers and asbestos workers. In trials looking at multivitamins, there was no effect on fatal and nonfatal CVD events overall. One large trial did show a reduction in overall cancer incidence after 11.2 years of follow-up, while another showed a protective effect among men (adjusted relative risk, 0.69 [95% CI, 0.53 to 0.91]) but not among women.  Taken together, these two trials (n = 27,658) reported lower overall cancer incidence in men taking a multivitamin for more than 10 years (pooled unadjusted relative risk, 0.94 [95% CI, 0.89 to 1.00]).

By Sarah Chuzi and Aimee Li, MD

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: supplementsvitamins
Previous Post

The HAS-BLED score: Bleeding risk in atrial fibrillation [Classics Series]

Next Post

Low brown fat may explain increased susceptibility to type 2 diabetes in south Asians

RelatedReports

The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 45

July 29, 2024
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Multivitamin use not found to be associated with mortality benefit at 20 years follow-up

July 6, 2024
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 39

May 2, 2024
Provision of medically-tailored meals linked with lower admissions and medical spending
Wellness

Wellness Check: Nutrition

December 7, 2023
Next Post
Costs for DKA care vary significantly among U.S. hospitals

Low brown fat may explain increased susceptibility to type 2 diabetes in south Asians

Bariatric surgery is an effective option for weight loss and glycemic control

Obesity without metabolic syndrome still associated with increased mortality

New gene variants linked with Alzheimer Disease in African Americans

PET scans accurately identify amyloid deposition after traumatic brain injury

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.